Significant events during 2024 NAV as of 31 December 2024: €1,280.0m (€35.06 per share), up 1.4% including the dividend paid in May 2024 (€1.08 per share) Weighted average EBITDA of portfolio companie ...

Latham describes it as the largest LBO of the year so far and the third-largest healthcare LBO of all time in the U.S. & ...

Latham describes it as the largest LBO of the year so far and the third-largest healthcare LBO of all time in the U.S. & ...

Strong returns in U.S. stocks, particularly over the past two plus years, have led investors to question the relative lack of ...

Heading into 2025, a handful of mega-cap tech companies had tilted the U.S. public equity markets meaningfully into growth ...

Back in 1934, Ralph Nelson Elliott discovered that price action displayed on charts, instead of behaving in a somewhat chaotic manner, had actually an intrinsic narrative attached. Elliot saw the ...

The Northern Territory's corruption watchdog has been accused of being a toothless tiger. But after millions of dollars and a rocky first few years, there's an argument that it's finally doing its ...

An analysis cited in HealthExec of the Walgreens buy from the SEC 8-K filing indicates that Sycamore Partners’ offer is a near-classic leveraged buyout, with Sycamore taking on much more debt than ...

Financial modeling provides businesses with an overview of their past, present, and expected future performance. Learn how it ...